Skip to main content

Forefront Analytics, LLC

SEC CIK
0001696802
Latest filing
Aug 12, 2026

Holdings changes from Q3 2024 to Q4 2024

Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.

Choose two quarters to compare

New
4
Est. +$19.4M
Added
35
Est. +$41.6M
Reduced
25
Est. −$36.8M
Sold out
7
Est. −$12.7M

Portfolio value went from $212.0M to $215.0M (+$2.98M (+1.4%)); positions from 67 to 64 (−3).

All Q4 2024 holdingsAll Q3 2024 holdings

In the shares, value and % of portfolio columns, the top figure is Q4 2024 and the gray one below is Q3 2024. For stocks that split between the two quarters, Q3 2024 shares are converted at the split ratio before comparing.

Holdings of Forefront Analytics, LLC in Q3 2024 and Q4 2024 compared
SecurityActionSharesShare changeValueEst. bought or sold% of portfolioWeight change (pp)
CTMXCytomX Therapeutics, Inc.AddedHistory64,25959,760+4,499+7.5%$66.2K$70.5K+$4.63K<0.1%<0.1%0.00
GERNGeron CorpAddedHistory19,02318,491+532+2.9%$67.3K$83.9K+$1.88K<0.1%<0.1%−0.01
NKTXNkarta, Inc.AddedHistory30,04617,646+12,400+70.3%$74.8K$79.8K+$30.9K<0.1%<0.1%0.00
ANNXAnnexon, Inc.AddedHistory16,43310,483+5,950+56.8%$84.3K$62.1K+$30.5K<0.1%<0.1%+0.01
KRONKronos Bio, Inc.AddedHistory93,19090,998+2,192+2.4%$88.5K$91.0K+$2.08K<0.1%<0.1%0.00
COGTCogent Biosciences, Inc.AddedHistory13,76010,021+3,739+37.3%$107.3K$108.2K+$29.2K<0.1%0.1%0.00
IMTXImmatics N.V.AddedHistory15,91111,180+4,731+42.3%$113.1K$127.6K+$33.6K0.1%0.1%−0.01
MREOMereo BioPharma Group plcAddedHistory34,75333,800+953+2.8%$121.6K$138.9K+$3.34K0.1%0.1%−0.01
ZURAZura Bio LtdAddedHistory53,73430,810+22,924+74.4%$134.3K$125.1K+$57.3K0.1%0.1%0.00
EWEdwards Lifesciences CorpAddedHistory3,2263,142+84+2.7%$238.8K$207.3K+$6.22K0.1%0.1%+0.01
MDTMedtronic plcAddedHistory3,0772,323+754+32.5%$245.9K$209.2K+$60.3K0.1%0.1%+0.02
REGNRegeneron Pharmaceuticals, Inc.AddedHistory368297+71+23.9%$262.1K$312.2K+$50.6K0.1%0.1%−0.03
PFEPfizer IncAddedHistory14,90314,294+609+4.3%$395.4K$413.6K+$16.2K0.2%0.2%−0.01
UNHUnitedHealth Group IncAddedHistory787733+54+7.4%$400.4K$430.8K+$27.5K0.2%0.2%−0.02
DEDeere & CoAddedHistory1,1181,114+4+0.4%$473.8K$464.9K+$1.70K0.2%0.2%0.00
iShares Tr464288513Added–6,7082,889+3,819+132.2%$527.6K$232.1K+$300.4K0.2%0.1%+0.14
JPMJPMorgan Chase & CoAddedHistory3,3453,281+64+2.0%$801.8K$691.8K+$15.3K0.4%0.3%+0.05
iShares Tr46429B655Added–25,03412,189+12,845+105.4%$1.27M$622.1K+$653.5K0.6%0.3%+0.30
iShares Inc46434G509Added–63,02662,806+220+0.4%$1.70M$1.78M+$5.95K0.8%0.8%−0.05
iShares Tr464287440Added–19,08814,150+4,938+34.9%$1.76M$1.39M+$456.5K0.8%0.7%+0.17
Vanguard Morningstar Value ETF922908744Added–13,1548,069+5,085+63.0%$2.23M$1.41M+$861.0K1.0%0.7%+0.37
iShares Tr46429B747Added–24,89716,389+8,508+51.9%$2.50M$1.66M+$855.9K1.2%0.8%+0.38
iShares Tr464288661Added–23,72710,766+12,961+120.4%$2.74M$1.29M+$1.50M1.3%0.6%+0.67
Vanguard Real Estate ETF922908553Added–43,42228,485+14,937+52.4%$3.87M$2.78M+$1.33M1.8%1.3%+0.49
iShares MSCI USA Min Vol Factor ETF46429B697Added–45,30811,788+33,520+284.4%$4.02M$1.08M+$2.98M1.9%0.5%+1.36
SPDR Series Trust78468R200Added–160,00864,837+95,171+146.8%$4.92M$2.00M+$2.92M2.3%0.9%+1.34
iShares Tips Bond ETF464287176Added–57,32919,077+38,252+200.5%$6.11M$2.11M+$4.08M2.8%1.0%+1.85
Invesco Exch Traded FD Tr II46138G508Added–304,746280,587+24,159+8.6%$6.42M$5.90M+$509.0K3.0%2.8%+0.21
iShares Tr464288588Added–72,36359,615+12,748+21.4%$6.63M$5.71M+$1.17M3.1%2.7%+0.39
Vanguard World FD921910709Added–109,78083,754+26,026+31.1%$7.43M$6.67M+$1.76M3.5%3.1%+0.31
Vanguard Intl Equity Index F922042676Added–198,72152,941+145,780+275.4%$7.86M$2.48M+$5.77M3.7%1.2%+2.48
SPDR Series Trust78464A490Added–217,606150,079+67,527+45.0%$7.87M$6.05M+$2.44M3.7%2.9%+0.81
iShares MSCI USA Momentum Factor ETF46432F396Added–38,94533,712+5,233+15.5%$8.06M$6.84M+$1.08M3.7%3.2%+0.52
iShares Tr464288281Added–147,40067,741+79,659+117.6%$13.1M$6.34M+$7.09M6.1%3.0%+3.11
Vanguard Total International Bond ETF92203J407Added–318,115206,961+111,154+53.7%$15.6M$10.4M+$5.45M7.3%4.9%+2.35

Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.